Official Ground-breaking Ceremony of Wuhan Synthetic Biology Innovation Center & CABIO R&D Center Investment Project
Comunicato Precedente
Comunicato Successivo
CABIO is a high and new technology enterprise primarily driven by biotechnology as its core competency. After two decades of accumulation, CABIO has developed a leading industry platform technology system founded upon synthetic biology, directional selection and breeding of industrial strains, fine regulation of fermentation, and other biotechnologies. In light of advancements in synthetic biology, CABIO has increased investment in said field, constructed a synthetic biology lab, and initiated a series of technologically far-sighted research projects teeming with market potential.
After years of accumulation, CABIO has grown from a start-up into a star in the scientific and technological innovation capital market, and since then, it has ascended as one of the most renowned research-oriented public synthetic biology companies.
During the ground-breaking ceremony of the innovation center, CABIO also officially unveiled its brand new synthetic biology-based product line: HMOs series, lipid nutrient series, high value-added personal care ingredients, and so forth. In the future, CABIO will continue to roll out brand new products armed with synthetic biology-based disruptive technology, reinforce the company's development strategy centering on nutrients for humans and supplemented by nutrients for animals and functional care product raw materials, and realize high-quality growth and sustainable development.
Photo - https://mma.prnewswire.com/media/1925741/Official_Ground_breaking_Ceremony_of_Wuhan_Synthetic_Biology_Innovation_Center___CABIO_R_D_Center_In.jpg
View original content:https://www.prnewswire.co.uk/news-releases/official-ground-breaking-ceremony-of-wuhan-synthetic-biology-innovation-center--cabio-rd-center-investment-project-301654739.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




